Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Logan JE and Roudebush WE | Platelet-activating factor increases intracellular calcium levels in preimplantation stage embryos. | 2000 | Early Pregnancy | pmid:11719820 |
Claman P | Platelet activating factor does not improve intrauterine insemination outcome. | 2001 | Am. J. Obstet. Gynecol. | pmid:11717679 |
Macphee CH | Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. | 2001 | Curr Opin Pharmacol | pmid:11714085 |
Suwaki T et al. | Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug. | 2001 | Int. Immunopharmacol. | pmid:11710545 |
Ibe BO et al. | Maturational changes in ovine pulmonary metabolism of platelet-activating factor: implications for postnatal adaptation. | 2001 | Mol. Genet. Metab. | pmid:11708870 |
Bernatchez PN et al. | Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways. | 2001 | Br. J. Pharmacol. | pmid:11704645 |
Masuhara K et al. | Involvement of platelet activation in experimental osteonecrosis in rabbits. | 2001 | Int J Exp Pathol | pmid:11703540 |
Adams JM et al. | Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock. | 2001 | Crit. Care Med. | pmid:11700422 |
Houghton TJ et al. | Efficient assembly of the phomactin core via two different macrocyclization protocols. | 2001 | Org. Lett. | pmid:11700095 |
Lendvai B et al. | Platelet-activating factor evokes Ca2+ transients after the blockade of ryanodine receptor by dantrolene in RAW 264.7 macrophages. | 2001 | Neurochem. Res. | pmid:11699928 |
Casao MA et al. | Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies. | 2001 | J. Med. Microbiol. | pmid:11699593 |
Kaul DK et al. | Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. | 2001 | Blood | pmid:11698300 |
den Dekker E et al. | Biogenesis of G-protein mediated calcium signaling in human megakaryocytes. | 2001 | Thromb. Haemost. | pmid:11686331 |
Marathe GK et al. | Oxidized LDL contains inflammatory PAF-like phospholipids. | 2001 Apr-May | Trends Cardiovasc. Med. | pmid:11686003 |
Dutra PM et al. | Platelet-activating factor modulates a secreted phosphatase activity of the trypanosomatid parasite Herpetomonas muscarum muscarum. | 2001 | Curr. Microbiol. | pmid:11683365 |
Wielockx B et al. | Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor. | 2001 | J. Hepatol. | pmid:11682033 |
Pettorossi VE and Grassi S | Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. | 2001 | Acta Otolaryngol Suppl | pmid:11677732 |
Kohno S and Nabe T | [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)]. | 2001 | Nippon Rinsho | pmid:11676130 |
Camici M and Sagripanti A | Plasma platelet activating factor in nephrotic syndrome. | 2001 | Minerva Med. | pmid:11675576 |
Storey RF et al. | Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood. | 2001 | Platelets | pmid:11674863 |
Berdyshev EV et al. | Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. | 2001 | FASEB J. | pmid:11641243 |
Fabi F et al. | Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways. | 2001 | Br. J. Pharmacol. | pmid:11606318 |
Tsai MH et al. | Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells. | 2001 | Int. J. Oncol. | pmid:11605008 |
Yu P et al. | [Pathogenetic effect of platelet activating factor on enterogenic endotoxemia after burn]. | 1999 | Zhonghua Yi Xue Za Zhi | pmid:11601022 |
Havt A et al. | The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. | 2001 | Toxicon | pmid:11600146 |
Mathison R et al. | Regulation of leukocyte adhesion to heart by the tripeptides feG and feG(NH2). | 2001 | Can. J. Physiol. Pharmacol. | pmid:11599779 |
Sirolli V et al. | Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. | 2001 | Thromb. Haemost. | pmid:11583316 |
Jolly S et al. | Effect of intravenous platelet-activating factor on bovine pulmonary mast cells. | 2001 Aug-Oct | J. Comp. Pathol. | pmid:11578122 |
Christie PE and Henderson WR | Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. | 2002 | Clin Allergy Immunol | pmid:11577541 |
Mariano F et al. | Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. | 2001 | Kidney Int. | pmid:11576379 |
Khoo C et al. | Inhibition of store-operated Ca(2+) influx by acidic extracellular pH in cultured human microglia. | 2001 | Glia | pmid:11571781 |
Bhatia M et al. | Inflammatory mediators as therapeutic targets in acute pancreatitis. | 2001 | Curr Opin Investig Drugs | pmid:11566005 |
McKenna DJ et al. | Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. | 2001 Sep-Oct | Altern Ther Health Med | pmid:11565403 |
Zhao L et al. | Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. | 2001 | Br. J. Pharmacol. | pmid:11564653 |
Tsai JJ and Wang TF | Different densities of human eosinophils respond differently to PAF and IL-5. | 1999 | J Microbiol Immunol Infect | pmid:11561566 |
Fukunaga K et al. | Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. | 2001 | J. Biol. Chem. | pmid:11560941 |
Rozenfeld RA et al. | Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock. | 2001 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:11557516 |
Kavakli K et al. | Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease. | 2001 | Haemophilia | pmid:11554936 |
Chemler SR et al. | Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction. | 2001 | Org. Lett. | pmid:11554815 |
Denizot Y et al. | Is there a role of platelet-activating factor in human lung cancer? | 2001 Aug-Sep | Lung Cancer | pmid:11551414 |
Tokutomi T et al. | Production of platelet-activating factor by neuronal cells in the rat brain with cold injury. | 2001 | Neurol. Res. | pmid:11547929 |
Fazal N et al. | PAF receptor antagonist modulates neutrophil responses with thermal injury in vivo. | 2001 | Am. J. Physiol., Cell Physiol. | pmid:11546669 |
Steer ML | Relationship between pancreatitis and lung diseases. | 2001 | Respir Physiol | pmid:11535257 |
Stafforini DM | PAF acetylhydrolase gene polymorphisms and asthma severity. | 2001 | Pharmacogenomics | pmid:11535107 |
Watanabe S et al. | Suppression of platelet-activating factor generation and modulation of arachidonate metabolism by dietary enrichment with (n-9) eicosatrienoic acid or docosahexaenoic acid in mouse peritoneal cells. | 2001 | Prostaglandins Other Lipid Mediat. | pmid:11534547 |
Thomet OA et al. | Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. | 2001 | Clin. Exp. Allergy | pmid:11529903 |
Qian C et al. | Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. | 2001 | Pharmacol. Res. | pmid:11529688 |
McManus LM et al. | Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. | 2001 | J. Leukoc. Biol. | pmid:11527989 |
Emingil G et al. | Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. | 2001 | J. Periodontol. | pmid:11525434 |
Bernatchez PN et al. | VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2. | 2001 | Br. J. Pharmacol. | pmid:11522612 |
Dubois MJ and Vincent JL | Clinically-oriented therapies in sepsis: a review. | 2000 | J. Endotoxin Res. | pmid:11521072 |
Carceller E et al. | Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. | 2001 | J. Med. Chem. | pmid:11520209 |
Hoenstein R et al. | Interleukin-2 activates human peripheral blood eosinophils. | 2001 | Cell. Immunol. | pmid:11520078 |
Smith DG et al. | Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. | 2001 | J. Neurovirol. | pmid:11519483 |
Marathe GK et al. | Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. | 2001 | J. Lipid Res. | pmid:11518762 |
Mooren FC et al. | Decoupling of intracellular calcium signaling in granulocytes after exhaustive exercise. | 2001 | Int J Sports Med | pmid:11510867 |
Feldman C et al. | Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro. | 2001 | Eur. Respir. J. | pmid:11510782 |
Stoddart NR et al. | Exogenous platelet-activating factor stimulates cell proliferation in mouse pre-implantation embryos prior to the fourth cell cycle and shows isoform-specific stimulatory effects. | 2001 | Zygote | pmid:11510473 |
Hourton D et al. | Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity. | 2001 | Eur. J. Biochem. | pmid:11502209 |
Liu Y et al. | [The role and significance of PAF in the early pulmonary injury following burns combined with endotoxemia in rats]. | 1999 | Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi | pmid:11501075 |
Alvarez A and Sanz MJ | Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. | 2001 | J. Leukoc. Biol. | pmid:11493611 |
Hu LH et al. | Synthesis and biological activity of amide derivatives of ginkgolide A. | 2001 | J Asian Nat Prod Res | pmid:11491398 |
Coker A et al. | Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? | 2001 Jul-Aug | Hepatogastroenterology | pmid:11490817 |
Jantan I et al. | Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans. | 2001 | Planta Med. | pmid:11488464 |
Sachais BS | Platelet-endothelial interactions in atherosclerosis. | 2001 | Curr Atheroscler Rep | pmid:11487452 |
Hermoso M et al. | Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2. | 2001 | Pflugers Arch. | pmid:11484763 |
Chang PY et al. | Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. | 2001 | Circulation | pmid:11479258 |
Zhang J et al. | [Experimental study on effect of Buyang Huanwu decoction on arterial blood platelet activating factor content pre- and post-arterial thrombosis of rats]. | 1998 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:11475720 |
Akisu M et al. | The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis. | 2001 | Eur J Pediatr Surg | pmid:11475112 |
Velasquez LA et al. | PAF receptor and PAF acetylhydrolase expression in the endosalpinx of the human Fallopian tube: possible role of embryo-derived PAF in the control of embryo transport to the uterus. | 2001 | Hum. Reprod. | pmid:11473946 |
Lane JS et al. | Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. | 2001 | J. Surg. Res. | pmid:11469912 |
Hollmann MW et al. | Local anesthetic effects on priming and activation of human neutrophils. | 2001 | Anesthesiology | pmid:11465548 |
Raggers RJ et al. | Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. | 2001 | Biochem. J. | pmid:11463358 |
Grosman N | Similar effects of ether phospholipids, PAF and lyso-PAF on the Ca(2+)-ATPase activity of rat brain synaptosomes and leukocyte membranes. | 2001 | Int. Immunopharmacol. | pmid:11460312 |
Thom SR et al. | Roles for platelet-activating factor and *NO-derived oxidants causing neutrophil adherence after CO poisoning. | 2001 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11454599 |
Miguel BG et al. | Increase of phosphoinositide hydrolysis and diacylglycerol production by PAF in isolated rat liver nuclei. | 2001 | Prostaglandins Other Lipid Mediat. | pmid:11444588 |
Tsoukatos DC et al. | Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. | 2001 | Biochem. J. | pmid:11439095 |
Wang H et al. | Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. | 2001 | Br. J. Pharmacol. | pmid:11429396 |
Virchow JC et al. | Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. | 2001 | Clin. Exp. Allergy | pmid:11422147 |
Kulikov VI and Muzya GI | Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs. | 2001 | Biochemistry Mosc. | pmid:11421815 |
Jehle R et al. | Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. | 2001 | Biochim. Biophys. Acta | pmid:11420174 |
Mizuno S et al. | Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells. | 2001 | Dig. Dis. Sci. | pmid:11414308 |
Briton-Jones C et al. | The effects of follicular fluid and platelet-activating factor on motion characteristics of poor-quality cryopreserved human sperm. | 2001 | J. Assist. Reprod. Genet. | pmid:11411433 |
Burke JR et al. | BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. | 2001 | J. Pharmacol. Exp. Ther. | pmid:11408565 |
Roudebush WE | Role of platelet-activating factor in reproduction: sperm function. | 2001 | Asian J. Androl. | pmid:11404790 |
Tong N et al. | Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. | 2001 | Eur. J. Neurosci. | pmid:11403684 |
Tiemann U et al. | Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy. | 2001 | Prostaglandins Other Lipid Mediat. | pmid:11403499 |
Elzi DJ et al. | Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils. | 2001 | Am. J. Physiol., Cell Physiol. | pmid:11401859 |
Roudebush WE and Diehl JR | Platelet-activating factor content in boar spermatozoa correlates with fertility. | 2001 | Theriogenology | pmid:11396471 |
Mi B and Maleczka RE | A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) coupling approach to the phomactins. | 2001 | Org. Lett. | pmid:11388849 |
Liu XH et al. | Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. | 2001 | Pediatr. Res. | pmid:11385142 |
Hirashima Y et al. | Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety. | 2001 | Neurol. Med. Chir. (Tokyo) | pmid:11381675 |
Rosa MS et al. | Platelet-activating factor (PAF) modulates peritoneal mouse macrophage infection by Leishmania amazonensis. | 2001 | Curr. Microbiol. | pmid:11375661 |
Iwase M et al. | Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. | 2001 | Crit. Care Med. | pmid:11373429 |
Tu W et al. | [Influences of BN50739 on neutrophil elastase and phospholipase A2 in lung and tracheal mucosa of pigs with acute severe pancreatitis]. | 2000 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:11372382 |
Lee T et al. | Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase. | 2001 | Arch. Biochem. Biophys. | pmid:11368182 |
Ferland C et al. | Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. | 2001 | J. Leukoc. Biol. | pmid:11358986 |
Taylor R et al. | Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction. | 2001 | Clin. Sci. | pmid:11352774 |
Wu C et al. | Evidence for the autocrine induction of capacitation of mammalian spermatozoa. | 2001 | J. Biol. Chem. | pmid:11350972 |
Wild MD and Roudebush WE | Platelet-activating factor improves intrauterine insemination outcome. | 2001 | Am. J. Obstet. Gynecol. | pmid:11349157 |